MusclePharm Corp (OTCMKTS:MSLP) major shareholder Wynnefield Partners Small Cap sold 300,000 shares of the company’s stock in a transaction that occurred on Wednesday, December 27th. The stock was sold at an average price of $1.00, for a total value of $300,000.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Shares of MusclePharm Corp (OTCMKTS:MSLP) opened at $0.95 on Friday. The company has a debt-to-equity ratio of -1.57, a current ratio of 1.17 and a quick ratio of 0.89. MusclePharm Corp has a twelve month low of $0.37 and a twelve month high of $2.25.
COPYRIGHT VIOLATION WARNING: This article was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another site, it was illegally stolen and reposted in violation of US and international copyright law. The original version of this article can be read at https://www.dispatchtribunal.com/2018/01/21/insider-selling-musclepharm-corp-mslp-major-shareholder-sells-300000-shares-of-stock.html.
MusclePharm Corporation is a performance lifestyle company. The Company develops, manufactures, markets and distributes branded nutritional supplements. The Company offers a range of powders, capsules, tablets and gels. The Company’s portfolio of brands targets various types of fitness enthusiasts, including professional, combat sport, weight training, bodybuilding, running, basketball, soccer, cross fit, golf, tennis, volleyball and other active lifestyle activities.
Receive News & Ratings for MusclePharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MusclePharm and related companies with MarketBeat.com's FREE daily email newsletter.